Dr Simon Crabb

University of Southampton

Dr Simon Crabb is an Associate Professor in Medical Oncology at the University of Southampton and an Honorary Consultant specialising in genitourinary cancers at University Hospital Southampton in the United Kingdom. His research interests are focussed on the development of novel therapeutic strategies for prostate and bladder cancers. Dr Crabb is Associate Clinical Director of the Southampton Clinical Trials Unit, Deputy Director of the Southampton Experimental Cancer Medicine Centre and a lead for phase I cancer clinical trials. He has been a member of NCRI Clinical Studies Groups for prostate cancer, and bladder and renal cancer and the Experimental Medicine Expert Review Panel for Cancer Research UK. Dr Crabb is an active clinical trialist including as Chief Investigator on the CRUK funded ProCAID and POLERISE trials in prostate cancer.

dont miss

Novel Therapeutic Strategies for Advanced Prostate Cancer

Prostate cancer continues to kill over 10,000 patients annually in the UK. Survival outcomes have extended in recent years through introduction of novel treatment strategies but in general, these have been modest gains. Rapid development in our understanding of disease biology, clonal evolution and intra-tumour heterogeneity are providing promise that we can develop more rationally targeted therapeutic strategies. This seminar will explore current examples of these approaches in clinical development.

EVEN MORE SEMINARS

  • Martyn Kennedy: Speaking at the Oncology Convention

    Martyn Kennedy
    Leeds Teaching Hospitals NHS Trust

    The Yorkshire Lung Screening Trial (YLST)

  • Corina van den Hurk: Speaking at the Oncology Convention

    Corina van den Hurk
    Netherlands Comprehensive Cancer Organisation

    Hair loss through chemotherapy is not inevitable!

  • Ms Claire Barnard: Speaking at the Oncology Convention

    Ms Claire Barnard
    GenesisCare

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

  • Andras Szasz: Speaking at the Oncology Convention

    Andras Szasz
    St. Istvan University

    Modulated electrohyperthermia (mEHT) for advanced malignant tumors

  • Dr. Anna ME Bruynzeel: Speaking at the Oncology Convention

    Dr. Anna ME Bruynzeel
    Amsterdam UMC (formerly VUmc)

    MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc